ID   PC-3-AR
AC   CVCL_C3HH
SY   PC3-AR
DR   cancercelllines; CVCL_C3HH
DR   GEO; GSM3407115
DR   GEO; GSM3407116
DR   GEO; GSM3407117
DR   GEO; GSM3407118
DR   GEO; GSM3407119
DR   GEO; GSM3407120
DR   GEO; GSM3407121
DR   GEO; GSM3407122
DR   GEO; GSM3407123
DR   Wikidata; Q114312649
RX   PubMed=30305041;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 644; AR.
CC   Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=30305041; DOI=10.1186/s12885-018-4848-x;
RA   Jividen K., Kedzierska K.Z., Yang C.-S., Szlachta K., Ratan A.,
RA   Paschal B.M.;
RT   "Genomic analysis of DNA repair genes and androgen signaling in
RT   prostate cancer.";
RL   BMC Cancer 18:960.1-960.20(2018).
//